Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 24 | 2024 | 627 | 4.210 |
Why?
|
| Registries | 16 | 2024 | 1379 | 1.040 |
Why?
|
| Peripartum Period | 2 | 2022 | 31 | 0.940 |
Why?
|
| Respiratory Insufficiency | 3 | 2021 | 234 | 0.860 |
Why?
|
| Hospital Mortality | 5 | 2024 | 1001 | 0.860 |
Why?
|
| Heart Defects, Congenital | 4 | 2023 | 1801 | 0.810 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2021 | 50 | 0.740 |
Why?
|
| Pregnant Women | 1 | 2022 | 148 | 0.720 |
Why?
|
| Critical Illness | 2 | 2024 | 594 | 0.700 |
Why?
|
| Survival Analysis | 1 | 2022 | 1466 | 0.600 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 130 | 0.590 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 180 | 0.560 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 273 | 0.510 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2024 | 312 | 0.510 |
Why?
|
| Heart-Assist Devices | 5 | 2022 | 1022 | 0.500 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 481 | 0.490 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 470 | 0.490 |
Why?
|
| Child Abuse | 1 | 2017 | 192 | 0.460 |
Why?
|
| Retrospective Studies | 21 | 2024 | 15916 | 0.460 |
Why?
|
| Survival Rate | 4 | 2024 | 1992 | 0.410 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 1192 | 0.410 |
Why?
|
| Heart Failure | 5 | 2022 | 2123 | 0.370 |
Why?
|
| Shock, Cardiogenic | 5 | 2024 | 189 | 0.340 |
Why?
|
| Anticoagulants | 2 | 2024 | 585 | 0.330 |
Why?
|
| Hypoxia | 2 | 2024 | 245 | 0.310 |
Why?
|
| Humans | 41 | 2024 | 122633 | 0.290 |
Why?
|
| Heart Transplantation | 3 | 2022 | 854 | 0.290 |
Why?
|
| Adult | 18 | 2024 | 28881 | 0.270 |
Why?
|
| Meningioma | 5 | 1998 | 103 | 0.250 |
Why?
|
| Child | 16 | 2024 | 24086 | 0.250 |
Why?
|
| Meningeal Neoplasms | 5 | 1998 | 167 | 0.240 |
Why?
|
| Cardiac Tamponade | 1 | 2023 | 37 | 0.220 |
Why?
|
| Female | 21 | 2024 | 65117 | 0.220 |
Why?
|
| Length of Stay | 2 | 2019 | 1281 | 0.220 |
Why?
|
| Infant | 8 | 2024 | 12272 | 0.210 |
Why?
|
| Compartment Syndromes | 1 | 2023 | 31 | 0.210 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2024 | 87 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 200 | 0.210 |
Why?
|
| Myositis | 1 | 2022 | 51 | 0.200 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2022 | 21 | 0.200 |
Why?
|
| Hydroxyurea | 3 | 1997 | 81 | 0.200 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2022 | 21 | 0.200 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2022 | 38 | 0.200 |
Why?
|
| Blood Pressure | 2 | 2024 | 1309 | 0.190 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 229 | 0.190 |
Why?
|
| Child, Preschool | 6 | 2024 | 13794 | 0.180 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 121 | 0.180 |
Why?
|
| Shock | 1 | 2022 | 89 | 0.180 |
Why?
|
| Morbidity | 1 | 2021 | 239 | 0.180 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 147 | 0.180 |
Why?
|
| Pregnancy | 3 | 2022 | 7105 | 0.170 |
Why?
|
| Risk Factors | 4 | 2023 | 9943 | 0.170 |
Why?
|
| Male | 18 | 2024 | 59714 | 0.170 |
Why?
|
| Antithrombins | 1 | 2019 | 55 | 0.170 |
Why?
|
| Postpartum Period | 1 | 2021 | 212 | 0.160 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 38 | 0.160 |
Why?
|
| Hospitals | 1 | 2021 | 397 | 0.160 |
Why?
|
| Thrombosis | 2 | 2024 | 517 | 0.160 |
Why?
|
| Vancomycin | 1 | 2020 | 217 | 0.150 |
Why?
|
| Critical Care | 2 | 2021 | 650 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2022 | 4686 | 0.150 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 439 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 229 | 0.150 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2019 | 341 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 172 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 288 | 0.140 |
Why?
|
| Veins | 1 | 2017 | 106 | 0.140 |
Why?
|
| Osteosarcoma | 1 | 2019 | 257 | 0.130 |
Why?
|
| Arteries | 1 | 2017 | 222 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2023 | 12055 | 0.130 |
Why?
|
| Adolescent | 6 | 2024 | 18987 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 360 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 376 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 426 | 0.120 |
Why?
|
| Status Asthmaticus | 1 | 2014 | 20 | 0.120 |
Why?
|
| Antineoplastic Agents | 4 | 1998 | 1675 | 0.110 |
Why?
|
| Anaphylaxis | 1 | 2014 | 77 | 0.110 |
Why?
|
| Young Adult | 3 | 2022 | 8817 | 0.110 |
Why?
|
| United States | 3 | 2024 | 10559 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8064 | 0.100 |
Why?
|
| Haemophilus Infections | 1 | 2012 | 92 | 0.100 |
Why?
|
| Haemophilus influenzae | 1 | 2012 | 130 | 0.100 |
Why?
|
| Incidence | 1 | 2019 | 3040 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 429 | 0.090 |
Why?
|
| Middle Aged | 9 | 2024 | 25849 | 0.080 |
Why?
|
| Time Factors | 1 | 2019 | 6188 | 0.080 |
Why?
|
| Sepsis | 1 | 2012 | 478 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 1101 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2022 | 848 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2015 | 1007 | 0.070 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 138 | 0.060 |
Why?
|
| Perioperative Period | 1 | 2024 | 49 | 0.060 |
Why?
|
| Hemolysis | 1 | 2024 | 105 | 0.060 |
Why?
|
| Fasciotomy | 1 | 2023 | 26 | 0.050 |
Why?
|
| Platelet Transfusion | 1 | 2023 | 53 | 0.050 |
Why?
|
| Platelet Count | 1 | 2023 | 133 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2015 | 357 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 131 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2004 | 197 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.050 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 35 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2024 | 196 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 263 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2023 | 302 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 606 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 485 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2024 | 458 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 169 | 0.050 |
Why?
|
| Ireland | 1 | 2020 | 27 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2023 | 333 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 87 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2004 | 555 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2019 | 41 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 419 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2024 | 488 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 156 | 0.040 |
Why?
|
| Aged | 4 | 2024 | 18982 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1683 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 236 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2024 | 734 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 37 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 101 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 1998 | 27 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 177 | 0.040 |
Why?
|
| Lymphokines | 1 | 1998 | 66 | 0.040 |
Why?
|
| Milk Proteins | 1 | 1998 | 91 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 598 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 455 | 0.040 |
Why?
|
| Body Composition | 1 | 2019 | 478 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2019 | 616 | 0.030 |
Why?
|
| Heart Atria | 1 | 2019 | 310 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 865 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 648 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1998 | 393 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 1996 | 98 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 779 | 0.030 |
Why?
|
| Peptides | 1 | 1998 | 798 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1162 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1104 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2004 | 2996 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6012 | 0.030 |
Why?
|
| Cytokines | 1 | 1998 | 1280 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 1730 | 0.020 |
Why?
|
| Cell Division | 3 | 1998 | 778 | 0.020 |
Why?
|
| Apoptosis | 1 | 1997 | 1782 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2395 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1997 | 3506 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1864 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 1063 | 0.020 |
Why?
|
| Constriction | 1 | 2004 | 48 | 0.020 |
Why?
|
| Intracranial Embolism | 1 | 2004 | 25 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 234 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2004 | 130 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 241 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 540 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1997 | 1114 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2004 | 923 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 516 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 1491 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1998 | 2 | 0.010 |
Why?
|
| Receptors, OSM-LIF | 1 | 1998 | 7 | 0.010 |
Why?
|
| Oncostatin M | 1 | 1998 | 6 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 1998 | 13 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1998 | 26 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1998 | 57 | 0.010 |
Why?
|
| Acute-Phase Proteins | 1 | 1998 | 46 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 1998 | 38 | 0.010 |
Why?
|
| Growth Substances | 1 | 1998 | 113 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1998 | 69 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 1998 | 89 | 0.010 |
Why?
|
| Cell Count | 1 | 1998 | 248 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 44 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1998 | 112 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 53 | 0.010 |
Why?
|
| Steroids | 1 | 1998 | 203 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1997 | 369 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1998 | 216 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1998 | 419 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1997 | 691 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1998 | 414 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1997 | 611 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1390 | 0.010 |
Why?
|
| Trans-Activators | 1 | 1998 | 798 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1695 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 1240 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 2047 | 0.010 |
Why?
|
| Prognosis | 1 | 1996 | 4488 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1998 | 4503 | 0.000 |
Why?
|
| Brain | 1 | 1996 | 2942 | 0.000 |
Why?
|
| Mice | 1 | 1997 | 17430 | 0.000 |
Why?
|
| Animals | 1 | 1997 | 33618 | 0.000 |
Why?
|